Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy

Keyphrases

• Cancer Therapy 100%
• Immunosuppressive Microenvironment 100%
• Malignancy 50%
• Myeloid Cells 50%
• Neoplasms 50%
• Small Molecules 50%
• Immune System 50%
• Cytokine Receptor 50%
• Prostaglandin E2 50%
• Therapeutic Goals 50%
• Lymphoid Cells 50%
• Radiotherapeutics 50%
• Tumor Escape 50%
• Tumor-infiltrating 50%
• Clinical Progress 50%
• Immunomodulatory Effect 50%
• Immunosurveillance 50%
• Anticancer Immune Response 50%
• 3-dioxigenase 50%
• Arginine Metabolism 50%
• Immunosuppressive Cells 50%
• Purinergic Signaling 50%
• Multiple Strategies 50%
• Immunotherapeutic Interventions 50%
• Indoleamine 50%
• Cytokine Modulator 50%
• Receptor Modulators 50%
• Immunosuppressive Network 50%

Immunology and Microbiology

• Immunosuppressive Drug 100%
• Myeloid 33%
• Immune Response 33%
• Intravenous Immunoglobulin 33%
• Prostaglandin E2 33%
• Cytokine Receptor 33%
• Immunosurveillance 33%
• Innate Lymphoid Cell 33%
• Tumor Escape 33%
• Immune System 33%
• Arginine 33%